According to the World Health Organization, over 50 million people worldwide live with dementia, and approximately 60-70 per cent of those cases are due to Alzheimer's disease.
FTD is an all-encompassing term for a group of brain disorders that threatens, as the name implies, the frontal and temporal lobes of the brain.
Identifying those at risk of dementia by recognising later-life changes in cognition is a step towards potentially preventing the disease or its progression.
The study shows that atherosclerosis and its associated risk factors, the main cause of cardiovascular disease, are also implicated in the cerebral alterations typically found in Alzheimer’s disease.
Researchers have been working tirelessly to develop innovative solutions for early Alzheimer's detection and prominent among research is the development of blood-based biomarker tests.
The man belongs to the same family of which 6,000 family members carry the gene presenilin-1, or PSEN1 - commonly known to raise the risk of Alzheimer's.
A research team from the US National Institutes of Health discovered several structural variants that could be risk factors to Lewy body dementia and frontotemporal dementia.
The study provides a quantitative understanding of the impact of chronic pain on cognitive function and the risk of dementia, laying an important foundation for future research.
Alzheimer’s disease is the most common cause of this though there are other conditions that can also lead to dementia.
Even when the disease is recognized it is often difficult to accept it, says Dr. Robert Mathew, former Professor of Neurology at Alappuzha Medical College and National President, ARDSI.